The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3591-3594

  Coffey, D C ^a   Kutko, M C ^a   Glick, R D ^a   Butler, L M ^a   Heller, G ^a   Rifkind, R A ^a   Marks, P A ^a   Richon, V M ^a   La Quaglia, M P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 CARBOXYCINNAMIC ACID BISHYDROXAMIDE; CINNAMIC ACID DERIVATIVE; HISTONE DEACETYLASE INHIBITOR; RETINOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR XENOGRAFT; WEIGHT REDUCTION;

ACETYLATION; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; CINNAMATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; FEMALE; GROWTH INHIBITORS; HISTONE DEACETYLASES; HISTONES; HUMANS; MICE; MICE, SCID; NEUROBLASTOMA; TRETINOIN; TUMOR CELLS, CULTURED; WEIGHT LOSS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035328528     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Overview: Biology of neuroblastoma
2. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
3. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
4. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
5. Histone acetylation and transcriptional regulatory mechanisms
6. The nucleosome: A powerful regulator of transcription
7. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
8. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines
9. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro
10. Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro
11. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
12. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-α2a in pediatric patients with refractory cancer
13. Augmentation of phenylbutyrate-induced differentiation of myeloid leukemia cells using all-trans retinoic acid
14. Antiproliferative activity and apoptosis induced by retinoic acid receptor-γ selectively binding retinoids in neuroblastoma
15. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
16. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the Children's Cancer Study Group
17. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60
18. Role of the histone deacetylase complex in acute promyelocytic leukaemia
19. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase